Physician profile
Michael Stein
NPI 1285907246
$938.98
in general payments reported to CMS, 2019-2025
9 companies · $592 in 2025
The $592 reported for 2025 was more than what 92% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $89.48 · 2021: $129 · 2022: $20.70 · 2023: $27.50 · 2024: $80.55 · 2025: $592.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $682 · Education: $18.09.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $681.70 |
| Education | $18.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aop Health US, LLC | $519.03 | 2025 | Rapiblyk |
| Atricure, INC. | $130.10 | 2020-2021 | |
| Edwards Lifesciences Corporation | $94.21 | 2020-2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Merck Sharp & Dohme LLC | $72.34 | 2021-2025 | Bridion |
| Medtronic, INC. | $48.20 | 2022-2023 | Mosaic |
| Octapharma USA, INC. | $27.39 | 2025 | Fibryga |
| Heron Therapeutics, INC. | $24.55 | 2025 | Aponvie |
| Avanos Medical | $11.86 | 2020 | |
| B. Braun Medical INC. | $11.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Stein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.